Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes

<p>Background: The burden of vascular diseases remains substantial in patients with type 2 diabetes, requiring identification of further risk markers. We tested the absence of dorsalis pedis and posterior tibial pulses as predictors of major macrovascular and microvascular events, death, and c...

Detaylı Bibliyografya
Asıl Yazarlar:	Mohammedi, K, Woodward, M, Zoungas, S, Q, L, Harrap, Stephen, S, Patel, A, Marre, M, Chalmers, J
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	American Diabetes Association 2016

Benzer Materyaller

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
Yazar:: Mohammedi, K, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
Yazar:: Mohammedi, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
Yazar:: Woodward, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
Yazar:: Blomster, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
Yazar:: Kamel Mohammedi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
Yazar:: Jun, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
Yazar:: Jun, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
Yazar:: Ohkuma, T, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Severe Hypoglycemia and Risks of Vascular Events and Death
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.
Yazar:: Hamet, P, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
Yazar:: Woodward, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
Yazar:: Philip M Clarke, ve diğerleri
Baskı/Yayın Bilgisi: (2010-02-01)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Yazar:: Patel, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
Yazar:: Ohkuma, T, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
Yazar:: Perkovic, V, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes: results from the ADVANCE study
Yazar:: Thomas, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
Yazar:: Mohammedi, K, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
Yazar:: Rahman, F, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
Yazar:: Ohkuma, T, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Microvascular outcomes in type 2 diabetes - Authors' reply
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
Yazar:: van Steen, S, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study.
Yazar:: Morton, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
Yazar:: Rådholm, K, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Outcomes of Vascular Intervention in Diabetic Patients with Peripheral Arterial Disease
Yazar:: Mahfujul Z. Haque, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Assessment of peripheral vascular function with photoplethysmographic pulse amplitude
Yazar:: Tatiana Kuznetsova, ve diğerleri
Baskı/Yayın Bilgisi: (2011-04-01)

Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
Yazar:: Selvin, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial
Yazar:: Merlin C. Thomas, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
Yazar:: Zoungas, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes
Yazar:: Zhang, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Yazar:: Patel, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review
Yazar:: Kamel Mohammedi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Decision‐making for early major amputation in selected diabetic foot ulcer patients with peripheral vascular disease
Yazar:: Lim York Tee Gorden, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
Yazar:: Hata, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
Yazar:: Welsh, P, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
Yazar:: Heart Protection Study Collaborative Group
Baskı/Yayın Bilgisi: (2007)

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
Yazar:: Kamel Mohammedi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Lowering blood pressure reduces renal events in type 2 diabetes.
Yazar:: de Galan, B, ve diğerleri
Baskı/Yayın Bilgisi: (2009)